Step by Stepa HemeOncBuddy patient portal

Fruquintinib

Illustration: Fruquintinib

Say it: froo-KWIN-tih-nib · Brand names: Fruzaqla

Fruquintinib is a targeted therapy pill that blocks the signals tumors use to grow new blood vessels.

What it is

Tumors need new blood vessels to bring them food and oxygen. Fruquintinib blocks proteins called VEGF receptors that help make these vessels. This can slow the growth of the cancer.

Often used for

How you get it

Fruquintinib is a capsule you take by mouth at home, once a day, with or without food. It is often taken for 3 weeks, followed by 1 week off, and then repeated. Your schedule may be different.

Common side effects and what helps

Call your care team right away if you have

Before you start, tell your team

Good to know

At home

Questions to ask

Side effect guides

Sources

Quick answers

What is Fruquintinib?
Fruquintinib is a targeted therapy pill that blocks the signals tumors use to grow new blood vessels. Brand names: Fruzaqla.
What is Fruquintinib used for?
colon or rectal cancer that has spread and has been treated with other medicines.
How is Fruquintinib given?
Fruquintinib is a capsule you take by mouth at home, once a day, with or without food. It is often taken for 3 weeks, followed by 1 week off, and then repeated. Your schedule may be different.
What are the common side effects of Fruquintinib?
High blood pressure. Redness, soreness, peeling, or blisters on the palms of your hands or soles of your feet. Protein in your urine, found on urine tests. A hoarse or changed voice. Belly pain. Diarrhea. Feeling tired or weak.
When should I call my care team while taking Fruquintinib?
A very bad headache, confusion, seizure, or changes in your eyesight; Bleeding that will not stop, vomiting blood, or black or bloody stools; Very bad belly pain that does not go away; Chest pain or pressure, or a racing or pounding heartbeat; Swelling, pain, or warmth in one leg, or sudden shortness of breath; Hives, swelling of your face or throat, or trouble breathing after a dose; A fever of 100.4 degrees Fahrenheit (38 degrees Celsius) or higher, or chills.

Last updated: 2026-10-27. Medically reviewed by Veli Bakalov, MD, medical oncologist (October 2026). General education from Step by Step, the patient portal of HemeOncBuddy.